Visualization of IL-22-expressing Lymphocytes Using Reporter Mice
January 25th, 2017
8.6K views
We describe here a transgenic reporter mouse model to visualize the IL-22-producing cells inside different mouse tissues. This method can be used to track the location of other cytokines or secretary proteins in the mouse.
Overview
This article describes a transgenic reporter mouse model designed to visualize IL-22-producing immune cells in various mouse tissues. This innovative method allows for tracking the location of cytokines and secretory proteins in vivo.
Key Study Components
Area of Science
- Neuroscience
- Immunology
- Transgenic Models
Background
- Immune cells release cytokines to combat foreign agents and repair tissues.
- IL-22 is a cytokine involved in tissue repair and pathology.
- Various immune cell types can produce IL-22.
- Understanding IL-22 production is crucial for studying immune responses.
Purpose of Study
- To identify and characterize IL-22-producing immune cells.
- To clarify which immune cells produce IL-22 under normal and inflammatory conditions.
- To develop a tool for tracking cytokine production in vivo.
Methods Used
- Creation of a transgenic IL-22 reporter mouse model.
- In vivo tracking of IL-22 producers in mouse tissues.
- Application of the model in an inflammatory bowel disease context.
- Characterization of immune cell types producing IL-22.
Main Results
- Successful identification of IL-22-producing cells in various tissues.
- Demonstration of the model's utility in studying immune responses.
- Insights into the role of IL-22 in health and disease.
- Potential applications for tracking other cytokines.
Conclusions
- The transgenic reporter mouse model is effective for visualizing IL-22 producers.
- This method enhances understanding of cytokine roles in immune responses.
- Future studies can utilize this model to explore other secretory proteins.
Frequently Asked Questions
What is the significance of IL-22 in the immune system?
IL-22 plays a critical role in tissue repair and can influence inflammatory responses.
How does the transgenic mouse model work?
The model expresses a reporter that allows visualization of IL-22-producing cells in vivo.
What are the potential applications of this research?
This research can help in understanding cytokine functions and developing therapies for immune-related diseases.
Can this model be used for other cytokines?
Yes, the method can be adapted to track other cytokines and secretory proteins.
What conditions were studied using this model?
The model was used to study IL-22 production under normal conditions and in an inflammatory bowel disease model.
What are the next steps in this research?
Future studies will focus on further characterizing the immune cells and exploring therapeutic implications.
Executive Industry Relevance
Transgenic IL-22 reporter mice enable direct visualization and isolation of cytokine-expressing lymphocytes in vivo, addressing a critical gap in immune cell target validation. This model supports mechanistic de-risking and predictive confidence for immunology-focused discovery pipelines, particularly in tissue repair and inflammation contexts. The approach enhances portfolio decision-making by providing high-fidelity, quantitative readouts of gene expression in disease-relevant systems.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables precise identification of IL-22-producing immune cell subsets in vivo for functional target validation.
- Supports mechanistic de-risking by clarifying which cell types contribute to cytokine-mediated tissue repair or pathology.
- Facilitates hypothesis-driven interrogation of immune pathways in both homeostatic and disease models.
Screening & Assay Development
- Provides validated biological systems for downstream flow cytometry and tissue imaging workflows.
- Delivers reproducible, quantitative fluorescent readouts for assay standardization and screening readiness.
- Enables scalable isolation and characterization of viable IL-22-expressing cells for compound evaluation.
Translational & Preclinical Research
- Aligns with disease-relevant models such as colitis to assess translational biomarker expression in situ.
- Supports continuity from discovery through preclinical validation by enabling longitudinal tracking of immune cell dynamics.
- Reduces biological ambiguity in preclinical advancement decisions by providing direct evidence of cytokine expression in target tissues.
Pipeline & Workflow Integration
This reporter mouse model integrates into the discovery-to-preclinical continuum, enabling target validation, mechanistic studies, and translational research in immune-mediated diseases.
- Discovery Biology: Supports hypothesis testing and pathway clarification by visualizing cytokine-producing cells in vivo.
- Screening: Delivers assay-ready, reproducible systems for quantitative analysis of immune cell subsets.
- Analytics: Provides robust flow cytometry and imaging outputs for comparative condition analysis.
- Translational Research: Bridges discovery and preclinical studies by enabling biomarker alignment in disease models.
- Enterprise Reuse: Offers a reusable platform for investigating additional secreted proteins or immune targets.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in immune target validation.
- Operational Value: Standardizes in vivo and ex vivo workflows for reproducibility and scalability.
- Strategic Value: Improves go/no-go decisions and capital efficiency by providing high-fidelity biological readouts.
- Portfolio Impact: Enables risk-adjusted prioritization and advancement of immune-modulating candidates.
Implementation Considerations
- Requires expertise in transgenic model generation and flow cytometry analysis.
- Demands access to molecular biology, animal facility, and imaging infrastructure.
- Necessitates cross-team standardization for tissue processing and data interpretation.
- Adaptable to other cytokines or secreted proteins with appropriate genetic engineering.
- Selection of BAC clones and validation of reporter fidelity are critical for reliable outputs.
Biopharma FAQs
Why does null hypothesis testing matter for IL-22 reporter validation?
Null hypothesis testing ensures that observed IL-22 reporter expression is statistically significant and not due to background fluorescence or unrelated genetic events. This rigor is essential for confirming true target validation and supporting mechanistic claims in immune cell studies.
How does independent variable isolation fit in BAC recombineering?
Isolating the BAC clone and controlling for insertion sites allows researchers to attribute observed reporter expression specifically to IL-22 gene activity. This isolation is critical for accurate discovery-stage interpretation and downstream assay development.
What do quantitative flow cytometry measurements enable in this model?
Quantitative flow cytometry provides precise enumeration and characterization of IL-22-expressing cells across tissues and conditions. These measurements enable comparative analysis, screening readiness, and robust data for cross-functional R&D teams.
Why are replication requirements important for tissue section analysis?
Replication ensures that tissue section findings are reproducible and not artifacts of sample preparation or imaging variability. This reliability is vital for cross-team collaboration and for building confidence in translational research outputs.
What statistical analysis capabilities are needed before flow cytometry implementation?
Robust statistical analysis is required to interpret flow cytometry data, distinguish true reporter-positive populations, and validate experimental reproducibility. These capabilities underpin reliable decision-making and portfolio advancement in biopharma R&D.
Chapters in this video
0:05
Title
3:22
Spleen, Thymus, Lymph Node, and Peyer's Patch Single Cell Suspension Generation
4:48
Intestinal Intraepithelial Lymphocyte and Lamina Propria Cell Isolation
1:49
Bacterial Artificial Chromosome (BAC) Recombineering of IL-22-tdTomato Vector Generation
6:40
IL-22-tdTomato Colitis Expression
7:57
Results: Representative Visualization and Localization of IL-22 Receptors
9:31
Conclusion
